Nurix Therapeutics Inc (NRIX)
ETFs that hold Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics Inc is held by 9 ETFs tracked in our database. The largest position is held by ARKG (2.69%). The remaining funds hold it at 0.58% or less. The largest holders are mostly sector and small-cap funds.
ETFs holding Nurix Therapeutics Inc (NRIX) in our database, ranked by portfolio weight.
Which ETFs hold Nurix Therapeutics Inc (NRIX)?
The ETFs with the largest positions in Nurix Therapeutics Inc (NRIX) are: ARK Genomic Revolution ETF (ARKG, 2.69%); SPDR S&P Biotech ETF (XBI, 0.58%); iShares Biotechnology ETF (IBB, 0.18%); iShares Russell 2000 Growth ETF (IWO, 0.12%); iShares Russell 2000 Value ETF (IWN, 0.11%). The full list, ranked by weight, is in the table.
How many ETFs hold Nurix Therapeutics Inc (NRIX)?
Nurix Therapeutics Inc (NRIX) is held by 9 ETFs tracked in our database. The largest position is in ARKG, where it makes up 2.69% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. ARKG holds Nurix Therapeutics Inc (NRIX) at 2.69%, and the simple average weight across the 9 funds is 0.42%.